A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

Clinical trial NCT02559570 · COMPLETED

Trial details

NCT number: NCT02559570
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Functional Constipation in Children Ages 6-17 Years

Start date: 2015-11-03
Primary completion: 2018-04-20
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.